ANKOOR SHAH, MD
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1841516895
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 780 | 23,120 | $15,530,820 | $4,768,178 | $3,771,407 |
| 2023 | 895 | 14,425 | $14,919,878 | $4,754,660 | $3,757,526 |
| 2022 | 878 | 12,270 | $9,362,191 | $4,683,628 | $3,703,496 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 5,640 | $33 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 5,460 | $147 | $117 |
| J0177 | Injection, aflibercept hd, 1 mg | 2,200 | $332 | $264 |
| J0178 | Injection, aflibercept, 1 mg | 2,160 | $821 | $654 |
| 92134 | Imaging of retina | 2,009 | $41 | $30 |
| 67028 | Injection of drug into eye | 1,602 | $135 | $103 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,417 | $228 | $181 |
| 92014 | Established patient complete exam of visual system | 1,236 | $126 | $91 |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 290 | $166 | $132 |
| J2778 | Injection, ranibizumab, 0.1 mg | 243 | $145 | $115 |
| 92250 | Photography of the retina | 120 | $37 | $29 |
| J3590 | Unclassified biologics | 108 | $2,661 | $2,117 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | Q3797 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | Q3797 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.